Cancer Research Institute
Cancer Research Institute reported $35.5 million in revenue and $42.1 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $79.19 went to program services, $9.29 to management and general costs and $11.52 to fundraising. Its largest source of revenue was contributions and grants: 75.2% of the total. The highest compensation it reported for one person was $747,735 (FORMER CEO (THRU 8/2024)). 15 people received more than $100,000 in reportable compensation. Revenue fell 5% between FY2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $42MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $35MThe 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 79.2% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 9.3% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 11.5% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.18 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 75.2% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 2.6% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $747,735 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 1.77% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 15 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 24.2 | 13.3 |
| Independent voting board members Part VI 1a–1b | 33 of 33 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseResearch: career development awards + translational innovation and clinical impact awards - see schedule ocri supports world-class scientists across career stages to drive discovery in cancer immunology and immunotherapy. Career development awards, including postdoctoral fellowships and the lloyd j. Old star program, provide flexible, multi-year funding to emerging and established investigators pursuing high-impact, innovative research. Awards range from approximately $243,000 over three years for fellowships to $1.25 million over five years for stars. Translational innovation and clinical…
Clinical - see schedule ocri accelerates the development of promising immunotherapies through early-phase clinical research and collaborative trials. The clinical innovator program supports novel clinical studies with funding of up to $1 million per trial, while the clinical accelerator is an actively managed venture philanthropy program that designs and conducts data-driven, multi-partner clinical studies in areas of high unmet need
Data - see schedule ocri advances the use of data to enable discovery, translation, and cross-study learning in immunotherapy research. Through support for data resources, analytic tools, and community guidance, cri supports initiatives that improve data quality, standardization, and interoperability across the field. These efforts help unlock insights into response and resistance and guide more effective development of immunotherapies
Highest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| FORMER CEO (THRU 8/2024) Officer, 40.00 hrs/week | $674,070 | $0 | $73,665 | $747,735 |
| FORMER CFO (THRU 2/2025) Officer, 40.00 hrs/week | $452,220 | $0 | $90,323 | $542,543 |
| CHIEF PROGRAM OFFICER Key employee, 40.00 hrs/week | $353,253 | $0 | $90,304 | $443,557 |
| CHIEF MARKETING OFFICER Key employee, 40.00 hrs/week | $377,547 | $0 | $53,116 | $430,663 |
| MANAGING DIR OF CRI CLINICAL ACCELERATOR Key employee, 40.00 hrs/week | $311,472 | $0 | $81,656 | $393,128 |
| CHIEF INFORMATION OFFICER Key employee, 40.00 hrs/week | $295,750 | $0 | $68,646 | $364,396 |
| CHIEF EXECUTIVE OFFICER Officer, 40.00 hrs/week | $241,026 | $0 | $0 | $241,026 |
| DIRECTOR OF SCIENTIFIC AFFAIRS Highest compensated employee, 40.00 hrs/week | $182,450 | $0 | $57,290 | $239,740 |
15 people received more than $100,000 in reportable compensation from Cancer Research Institute (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.9M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b33 · 33 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 531
- Volunteers Part I, line 6130
Largest outside contractors
FY2025 · Form 990, Part VII, Section B · businesses only| VIEWSTREAMCOMINC Web maintenance | $447,750 |
| NU ADVISORY PARTNERS LLC Recruiting services for CEO search | $230,323 |
| EISNERAMPER LLP Audit | $138,010 |
| EGON ZEHNDER INTERNATIONAL INC Recruiting services for CEO search | $133,733 |
| PRODUKTION INC Printing and mailing | $110,484 |
Individuals listed as contractors are left out. 6 contractors were paid more than $100,000 in all.
Private foundation grants it received
136 private foundations reported grants to Cancer Research Institute totaling $6.4M on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from Cancer Research Institute's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Cancer Research Institute, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Cancer Research Institute spent in FY2025, $79.19 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Nrg Oncology FoundationPhiladelphia, PA · revenue $35M · programs 96.8% · FY2025
- Palo Alto Veterans Institute for ResearchPalo Alto, CA · revenue $36M · programs 84.1% · FY2025
- Every CurePhiladelphia, PA · revenue $35M · programs 75.5% · 2025
- Bliss CaresOrlando, FL · revenue $37M · programs 97.8% · 2024
- The Foundation for AIDS ResearchNew York, NY · revenue $35M · programs 72.3% · FY2025
All medical research charities · Largest charities in New York
Questions people ask
How much of Cancer Research Institute's spending goes to programs?
In the fiscal year ending June 30, 2025, Cancer Research Institute reported that 79.2% of its $42.1 million in expenses went to program services, 9.3% to management and general and 11.5% to fundraising (Form 990, Part IX).
How much does Cancer Research Institute pay its top executive?
The largest total compensation Cancer Research Institute reported for one person in the fiscal year ending June 30, 2025 was $747,735, for the role of FORMER CEO (THRU 8/2024) (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Cancer Research Institute get its money?
Of $35.5 million in revenue in the fiscal year ending June 30, 2025, 75.2% came from contributions and grants and 2.6% from program service revenue (Form 990, Part VIII).
Is Cancer Research Institute a registered charity?
The IRS lists EIN 13-1837442 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202631349349308143 · read the filing
- FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202510629349301406 · read the filing
- FY2023: Form 990 for the fiscal year ending June 30, 2023, object 202440789349300344 · read the filing
- FY2022: Form 990 for the fiscal year ending June 30, 2022, object 202320389349301107 · read the filing
- FY2021: Form 990 for the fiscal year ending June 30, 2021, object 202210389349300206 · read the filing
- FY2020: Form 990 for the fiscal year ending June 30, 2020, object 202130209349300628 · read the filing
All filings for EIN 13-1837442: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.